Ezlor ST dispersible tablets 5mg, No. 10

Special Price $21.34 Regular Price $30.00
In stock
SKU
BIDL3177628
426.8 Reward Points will be used to purchase this product

Expiration Date: 05/2027

Russian Pharmacy name:

Эзлор СТ таблетки диспергируемые 5мг, №10

Ezlor ST dispersible tablets 5mg, No. 10; Seasonal allergic rhinitis, chronic idiopathic urticaria.

The method of application and dosage regimen of a particular drug depends on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly observe the compliance of the used dosage form of a particular drug with the indications for use and the dosage regimen.

Adults and adolescents aged 12 years and older are prescribed orally, regardless of food intake, at a dose of 5 mg / day.

Children aged 1 to 5 years - 1.25 mg 1 time / day, aged 6 to 11 years - 2.5 mg 1 time / day.

Dispersible tablets

active substance: desloratadine

Phenylketonuria, pregnancy, lactation, children under 1 year of age, hypersensitivity to desloratadine. Application during pregnancy and lactation Desloratadine is contraindicated for use during pregnancy and lactation (breastfeeding). Application for impaired renal function Desloratadine is prescribed with caution in severe renal failure.

pharmachologic effect

Blocker of histamine H1 receptors (long-acting). It is the primary active metabolite of loratadine. Inhibits the release of histamine and leukotriene C4 from mast cells. Prevents the development and facilitates the course of allergic reactions. It has antiallergic, antipruritic and antiexudative effect. Reduces capillary permeability, prevents the development of tissue edema, relieves smooth muscle spasm. It practically does not have a sedative effect and, when taken in a dose of 7.5 mg, does not affect the speed of psychomotor reactions. In comparative studies of desloratadine and loratadine, there were no qualitative or quantitative differences in the toxicity of the two drugs in comparable doses (taking into account the concentration of desloratadine).

Indications of the active substances of the drug

Seasonal allergic rhinitis, chronic idiopathic urticaria.

Dosage regimen

The method of application and dosage regimen of a particular drug depends on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly observe the compliance of the used dosage form of a particular drug with the indications for use and the dosage regimen.

Adults and adolescents aged 12 years and older are prescribed orally, regardless of food intake, at a dose of 5 mg / day.

Children aged 1 to 5 years - 1.25 mg 1 time / day, aged 6 to 11 years - 2.5 mg 1 time / day.

Side effect

From the nervous system: headache, hallucinations, psychomotor hyperreactivity, convulsions.

From the digestive system: dry mouth, hepatitis.

Others: photosensitivity, myalgia, shortness of breath, fatigue.

Contraindications for use

Phenylketonuria, pregnancy, lactation, children under 1 year of age, hypersensitivity to desloratadine. Application during pregnancy and lactation Desloratadine is contraindicated for use during pregnancy and lactation (breastfeeding). Application for impaired renal function Desloratadine is prescribed with caution in severe renal failure.

special instructions

Desloratadine is prescribed with caution in severe renal failure.

Influence on the ability to drive vehicles and use mechanisms

No adverse effects on driving or complex technical devices were noted.

Drug interactions

The study of interaction with ketoconazole and erythromycin did not reveal clinically significant changes.

Does not affect the effects of ethanol.

Submit your review to Earn 10 Reward Points click here to login

Write Your Own Review
You're reviewing:Ezlor ST dispersible tablets 5mg, No. 10

 Job in company (10-20 minutes a day | 400 - 1200 USD)! 

We are looking for partners!

 If you have PayPal and you are ready to earn in our team - contact us: [email protected] 

Copyright © 2011-2024 Buy-Pharm, Inc. All rights reserved.